MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/s41541-025-01174-1

Медицинская библиотека · NPJ vaccines · 2025

Next-gen novel nanocage-based multivalent vaccine candidate to tackle the rising menace of Mpox.

Ahuja Rahul, Vishwakarma Preeti, Kumar Varun, Khatri Ritika, Chatterjee Ananya, Mishra Surbhi, Rizvi Zaigham Abbas, Singh Anup, Kaur Gurleen, Maithil Vikas, Tarane Kunal, Chauhan Akanksha, Singh Sarjeet, Yadav Pooja, Yadav Devendra, Sinha Sangita Kumari, Ali Syed Khalid, Chatterjee Abhisek, Priyadarsiny Priyanka, Awasthi Amit, Prasad Vidya Mangala, Ahmed Shubbir, Samal Sweety

СтатьяПеревод в очереди

Аннотация

The recent emergence and global spread of the human Monkeypox virus (MPXV), including its transmission to non-endemic regions, have raised significant global health concerns. In this proof-of-concept study, we developed a recombinant protein-based MPXV vaccine candidate, employing an innovative and versatile multivalent, self-assembled nanocage protein scaffold. Two immunogenic antigens derived from the contemporary circulating MPXV strain have been incorporated into a self-assembled non-structural protein-10 (NSP-10) scaffold, expressed, and purified using an Escherichia coli expression system without a purification tag. The vaccine candidate elicited strong antibody responses in mice and conferred protection against the lethal Vaccinia virus in an intranasal and skin pock in vivo study. Additionally, an intranasal challenge with the MPXV strain clade IIb in immunized mice demonstrated promising outcomes, including a significant reduction in viral titres and eliciting a robust neutralizing antibody response. This study demonstrates a feasible, scalable, and cost-effective approach for the development of the MPXV vaccine.

Для цитирования: Ahuja Rahul, Vishwakarma Preeti, Kumar Varun, Khatri Ritika, Chatterjee Ananya, Mishra Surbhi, Rizvi Zaigham Abbas, Singh Anup, Kaur Gurleen, Maithil Vikas, Tarane Kunal, Chauhan Akanksha, Singh Sarjeet, Yadav Pooja, Yadav Devendra, Sinha Sangita Kumari, Ali Syed Khalid, Chatterjee Abhisek, Priyadarsiny Priyanka, Awasthi Amit, Prasad Vidya Mangala, Ahmed Shubbir, Samal Sweety. Next-gen novel nanocage-based multivalent vaccine candidate to tackle the rising menace of Mpox.. NPJ vaccines. 2025. DOI: 10.1038/s41541-025-01174-1.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.